In August of this year, the BCM3 antibody intermediate and conjugated stock solution dual-function production line and DP4 formulation workshop at the Singapore production site of Pharmaceutical Contract Research, Development and Production Outsourcing Company Pharmaceuticals were approved by GMP. This is the company's first overseas production site to be approved by GMP.

In August of this year, the BCM3 antibody intermediate and conjugated stock solution dual-function production line and DP4 formulation workshop at the Singapore production site of Pharmaceutical Contract Research, Development and Production Outsourcing Company Pharmaceuticals were approved by GMP. This is the company's first overseas production site to be approved by GMP.